Yang, Na
Sanofi (China)
3 papers on CoChatORCID 0000-0002-6805-8677
Most cited papers
- Verified
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
Sun, R., Yang, N., Kong, B., Cao, B., Feng, D., Yu, X., Ge, C., Huang, J., Shen, J., Wang, P., et al. (2017) · Molecular Pharmacology
Berberine and alkaloids researchDrug Transport and Resistance Mechanisms
Cited by 199
- Verified
Cognitive impairment in mice over-expressing γ-aminobutyric acid transporter I (GAT1)
Hu, J.-H., Ma, Y.-H., Jiang, J., Yang, N., Duan, S.-H., Jiang, Z.-H., Mei, Z.-T., Fei, J., & Guo, L.-H. (2004) · NeuroReport
Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms
Cited by 26
- Verified
Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study
Xie, P., He, X., Gao, X., Shuai, M., Schmider, W., Jiang, A., Yang, N., & Shi, A. (2023) · Diabetes Therapy
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free